Global Study on Bone Marrow Transplant Market, 2015-2021
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> B<strong>on</strong>e <strong>Marrow</strong> <strong>Transplant</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
Persistence <strong>Market</strong> Research Released New <strong>Market</strong> Report According to a new market report<br />
published by Persistence <strong>Market</strong> Research “<str<strong>on</strong>g>Global</str<strong>on</strong>g> <strong>Market</strong> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> B<strong>on</strong>e <strong>Marrow</strong><br />
<strong>Transplant</strong>: Latin America to Register Highest Growth Rate by <strong>2021</strong>, Owing to<br />
Increasing Density of B<strong>on</strong>e <strong>Marrow</strong> <strong>Transplant</strong> Centers”.<br />
Revenue from the global b<strong>on</strong>e marrow transplant market is anticipated to expand at a CAGR<br />
of 4.1% during the forecast period. By procedure type, the market is divided into segments<br />
viz. autologous b<strong>on</strong>e marrow transplant and allogeneic b<strong>on</strong>e marrow transplant. Allogeneic<br />
b<strong>on</strong>e marrow transplant procedure segment accounted for a highest revenue share of 63.4%<br />
in 2014, and revenue from this segment is expected to expand at CAGR of 4.4%, thereby<br />
accounting for market share to 65.7%. However, in terms of volume, the autologous b<strong>on</strong>e<br />
marrow transplant procedure segment is expected to c<strong>on</strong>tinue to lead the global b<strong>on</strong>e<br />
marrow transplant market as a result of increasing adopti<strong>on</strong> of the procedure owing to low<br />
chances of side effects. On the basis of disease indicati<strong>on</strong>s, the leukemia segment is<br />
expected to remain the leading segment and is expected to be valued at US$ 2,679.6 Mn by<br />
the end of <strong>2021</strong>. By disease indicati<strong>on</strong>, lymphoma segment currently ranks sec<strong>on</strong>d in terms<br />
of both value and volume.<br />
By end user, the market is segmented into hospitals, multispecialty clinics, and ambulatory<br />
surgical centers (ASC). Am<strong>on</strong>g these, hospital end user segment leads the global b<strong>on</strong>e<br />
marrow transplant market, accounting for over 91% volume share of global b<strong>on</strong>e marrow<br />
transplant market in 2014. This is partly attributed to requirement for advanced healthcare<br />
infrastructure for c<strong>on</strong>ducting the procedure. The multispecialty clinics segment is expected<br />
to register highest CAGR of 4.8% during the forecast period, with 1.4X increase in procedural<br />
count.<br />
<strong>Market</strong> growth is primarily driven by factors such as global increase in prevalence of blood<br />
cancers, expansi<strong>on</strong> of b<strong>on</strong>e marrow transplant registry, growing investment in logistic<br />
services, and improvement in survival rate after treatment. Being a procedure with the<br />
likelihood of highest success rate for the treatment of leukemia and other blood cancers,<br />
adopti<strong>on</strong> of b<strong>on</strong>e marrow transplant procedures is increasing, and is expected to fuel market<br />
growth to a significant extent over the forecast period. However, high cost of the treatment,<br />
scarcity of b<strong>on</strong>e marrow d<strong>on</strong>ors, and uncertainty of reimbursement in several developing<br />
Persistence <strong>Market</strong> Research 2
Change language